Strax

Autospela

Olaratumab + Doxorubicin for Metastatic Soft-Tissue Sarcoma

1 Visningar • 07/18/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

William D. Tap, MD; Richard F. Riedel, MD; Victor M. Villalobos, MD, PhD; and Kristen N. Ganjoo, MD, comment on the overall survival benefit seen in the phase II study of doxorubicin and olaratumab, the phase III ANNOUNCE trial, and patient selection for this regimen and data for other regimens.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela